In vitro effects of cinnamic acid derivatives on protein tyrosine phosphatase 1B

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 28, Issue 5, 2013, Pages 1067-1072

  Adisakwattana, Sirichai ^a   Pongsuwan, Jirawan ^a   Wungcharoen, Chompunut ^a   Yibchok Anun, Sirintorn ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Cinnamic acid derivatives; Kinetic inhibition; Protein tyrosine phosphatase 1B; Synergism

Indexed keywords

1,2 HYDROXYCINNAMIC ACID; 1,2 METHOXYCINNAMIC ACID; 1,3 HYDROXYCINNAMIC ACID; 1,3 METHOXYCINNAMIC ACID; 1,4 HYDROXYCINNAMIC ACID; 1,4 METHOXYCINNAMIC ACID; 3,4 DIMETHOXYCINNAMIC ACID; CAFFEIC ACID; CINNAMALDEHYDE; CINNAMIC ACID DERIVATIVE; CINNAMIC ACID METHYL ESTER; CINNAMYL ALCOHOL; FERULIC ACID; ISOFERULIC ACID; PROTEIN TYROSINE PHOSPHATASE 1B; UNCLASSIFIED DRUG; VANADATE SODIUM;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME KINETICS; HUMAN; IC 50; IN VITRO STUDY; PRIORITY JOURNAL;

CINNAMATES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HUMANS; MOLECULAR STRUCTURE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84884236608     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.3109/14756366.2012.715286     Document Type: Article

References (35)

1. Drake PG, Posner BI. Insulin receptor-associated protein tyrosine phosphatase(s): Role in insulin action. Mol Cell Biochem 1998;182:79-89.
2. Zhang S, Zhang ZY. PTP1B as a drug target: Recent developments in PTP1B inhibitor discovery. Drug Discov Today 2007;12:373-381.
3. Wu X, Hardy VE, Joseph JI, Jabbour S, Mahadev K, Zhu L et al. Protein-tyrosine phosphatase activity in human adipocytes is strongly correlated with insulin-stimulated glucose uptake and is a target of insulin-induced oxidative inhibition. Metab Clin Exp 2003;52:705-712.
4. Ma YM, Tao RY, Liu Q, Li J, Tian JY, Zhang XL et al. PTP1B inhibitor improves both insulin resistance and lipid abnormalities in vivo and in vitro. Mol Cell Biochem 2011;357:65-72.
5. Mohammad A, Wang J, McNeill JH. Bis(maltolato)oxovanadium(IV) inhibits the activity of PTP1B in Zucker rat skeletal muscle in vivo. Mol Cell Biochem 2002;229:125-128.
6. Hanhineva K, Törrönen R, Bondia-Pons I, Pekkinen J, Kolehmainen M, Mykkänen H et al. Impact of dietary polyphenols on carbohydrate metabolism. Int J Mol Sci 2010;11:1365-1402.
7. Natella F, Nardini M, Di Felice M, Scaccini C. Benzoic and cinnamic acid derivatives as antioxidants: Structure-activity relation. J Agric Food Chem 1999;47:1453-1459.
8. Lee EJ, Kim SR, Kim J, Kim YC. Hepatoprotective phenylpropanoids from Scrophularia buergeriana roots against CCl(4)-induced toxicity: Action mechanism and structure-activity relationship. Planta Med 2002;68:407-411.
9. Lee HS. Tyrosinase inhibitors of Pulsatilla cernua root-derived materials. J Agric Food Chem 2002;50:1400-1403.
10. Liu IM, Hsu FL, Chen CF, Cheng JT. Antihyperglycemic action of isoferulic acid in streptozotocin-induced diabetic rats. Br J Pharmacol 2000;129:631-636.
11. Adisakwattana S, Sookkongwaree K, Roengsumran S, Petsom A, Ngamrojnavanich N, Chavasiri W et al. Structure-activity relationships of trans-cinnamic acid derivatives on alphaglucosidase inhibition. Bioorg Med Chem Lett 2004;14:2893-2896.
12. Adisakwattana S, Chantarasinlapin P, Thammarat H, Yibchok- Anun S. A series of cinnamic acid derivatives and their inhibitory activity on intestinal alpha-glucosidase. J Enzyme Inhib Med Chem 2009;24:1194-1200.
13. Adisakwattana S, Moonsan P, Yibchok-Anun S. Insulin-releasing properties of a series of cinnamic acid derivatives in vitro and in vivo. J Agric Food Chem 2008;56:7838-7844.
14. Yibchok-anun S, Adisakwattana S, Moonsan P, Hsu WH. Insulinsecretagogue activity of p-methoxycinnamic acid in rats, perfused rat pancreas and pancreatic beta-cell line. Basic Clin Pharmacol Toxicol 2008;102:476-482.
15. Chang HK, Hsu FL, Liu IM, Cheng JT. Stimulatory effect of cinnamic acid analogues on alpha1A-adrenoceptors in-vitro. J Pharm Pharmacol 2003;55:833-837.
16. Huang DW, Shen SC, Wu JS. Effects of caffeic acid and cinnamic acid on glucose uptake in insulin-resistant mouse hepatocytes. J Agric Food Chem 2009;57:7687-7692.
17. Adisakwattana S, Sompong W, Meeprom A, Ngamukote S, Yibchok- Anun S. Cinnamic Acid and its derivatives inhibit fructosemediated protein glycation. Int J Mol Sci 2012;13:1778-1789.
18. Lub ben T, Clampit J, Stashko M, Revillyan JT, Jirousek MR. In vitro enzymatic assays of protein tyrosine phosphatase 1B. In: Enna SJ, Willams M, eds. Current Protocols in Pharmacology. Chichester: Wiley; 2001. P3.8.1-3.8.13.
19. Manach C, Scalbert A, Morand C, Rémésy C, Jiménez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004;79:727-747.
20. Cho AS, Jeon SM, Kim MJ, Yeo J, Seo KI, Choi MS et al. Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced-obese mice. Food Chem Toxicol 2010;48:937-943.
21. Radtke J, Linseisen J, Wolfram G. Phenolic acid intake of adults in a Bavarian subgroup of the national food consumption survey. Z Ernahrungswiss 1998;37:190-197.
22. Clifford MN. Chlorogenic acids and other cinnamates-nature, occurrence and dietary burden. J Sci Food Agric 1999;320:362-372.
23. Ohara K, Uchida A, Nagasaka R, Ushio H, Ohshima T. The effects of hydroxycinnamic acid derivatives on adiponectin secretion. Phytomedicine 2009;16:130-137.
24. Prabhakar PK, Doble M. Interaction of cinnamic acid derivatives with commercial hypoglycemic drugs on 2-deoxyglucose uptake in 3T3-L1 adipocytes. J Agric Food Chem 2011;59: 9835-9844.
25. Wiesmann C, Barr KJ, Kung J, Zhu J, Erlanson DA, Shen W, Fahr BJ, Zhong M, Taylor L, Randal M, McDowell RS, Hansen SK. Allosteric inhibition of protein tyrosine phosphatase 1B. Nat Struct Mol Biol 2004;11:730-737.
26. Seo C, Sohn JH, Ahn JS, Yim JH, Lee HK, Oh H.Protein tyrosine phosphatase 1B inhibitory effects of depsidone and pseudodepsidone metabolites from the Antarctic lichen Stereocaulon alpinum. Bioorg Med Chem Lett 2009;19:2801-2803.
27. Sun T, Wang Q, Yu Z, Zhang Y, Guo Y, Chen K, Shen X, Jiang H. Hyrtiosal, a PTP1B inhibitor from the marine sponge Hyrtios erectus, shows extensive cellular effects on PI3K/AKT activation, glucose transport, and TGFbeta/Smad2 signaling. Chembiochem 2007;8:187-193.
28. Fantus IG, Deragon G, Lai R, Tang S. Modulation of insulin action by vanadate: Evidence of a role for phosphotyrosine phosphatase activity to alter cellular signaling. Mol Cell Biochem 1995;153:103-112.
29. Huyer G, Liu S, Kelly J, Moffat J, Payette P, Kennedy B, Tsaprailis G, Gresser MJ, Ramachandran C. Mechanism of inhibition of proteintyrosine phosphatases by vanadate and pervanadate. J Biol Chem 1997;272:84-851.
30. Thompson KH, Lichter J, LeBel C, Scaife MC, McNeill JH, Orvig C. Vanadium treatment of type 2 diabetes: A view to the future. J Inorg Biochem 2009;103:554-558.
31. Ramasarma T. Vanadium complexes with insulin-mimetic actions-A second line of protection against diabetes. Indian J Clin Biochem 1996:11; 92-107.
32. Domingo JL. Vanadium and Tungsten derivatives as antidiabetic agents: A review of their toxic effects. Biol Trace Elem Res 2002;88:97-112.
33. Barrio DA, Etcheverry SB. Potential use of vanadium compounds in therapeutics. Curr Med Chem 2010;17:3632-3642.
34. Yadav UC, Moorthy K, Baquer NZ. Combined treatment of sodium orthovanadate and Momordica charantia fruit extract prevents alterations in lipid profile and lipogenic enzymes in alloxan diabetic rats. Mol Cell Biochem 2005;268(1-2):111-20.
35. Yadav UC, Moorthy K, Baquer NZ. Effects of sodium-orthovanadate and Trigonella foenum-graecum seeds on hepatic and renal lipogenic enzymes and lipid profile during alloxan diabetes. J Biosci 2004;29:81-91.